Tech Company Financing Transactions
Orbital Therapeutics Funding Round
On 4/26/2023, Orbital Therapeutics landed $270 million in Series A funding from Arch Venture Partners, ADG Venture and Agent Capital.
Transaction Overview
Company Name
Announced On
4/26/2023
Transaction Type
Venture Equity
Amount
$270,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand the applicability of RNA-based medicines across a range of human diseases, including in the areas of next-generation vaccines, immunomodulation, and protein replacement.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
21 Erie St
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines (excluding small interfering RNA) to treat human disease in ways that were not previously possible. The company is building a first-in-kind platform at the intersection of RNA technology, delivery methods, data science and automation to develop an expansive portfolio of medicines, initially focused in the areas of vaccines, immunomodulation, and protein replacement. Founded by experts in the fields of genetic medicine and RNA development and delivery, Orbital has an operational structure designed to harness the ingenuity of a deep and diverse team of scientists, drug developers and business leaders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
John Maraganore
Chief Executive Officer
Giuseppe Ciaramella
Chief Financial Officer
Jonathan Piazza
Chief Operating Officer
Niru Subramanian
Chief Scientific Officer
Gilles Besin
Co-Founder
Kristina Burow
Browse more venture capital transactions:
Prev: 4/26/2023: Relay venture capital transaction
Next: 4/26/2023: TympaHealth venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs